Aretha-1 Initial Efficacy and Safety Data in mTNBC Patients To Be Presented at SABCS

Safety Run-in Cohort Results Show Anti-tumor Activity Plus Systemic Metabolic Improvements with Evexomostat Plus Eribulin in Late-line Metastatic TNBC Patients to be Presented at SABCS 2025